Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels

Clinical and Vaccine Immunology

Volumn 23, Issue 3, 2016, Pages 243-245

  Vissers, Marloes ^a   Ahout, Inge M L ^a   De Jonge, Marien I ^a   Ferwerda, Gerben ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; CXCL10 PROTEIN, HUMAN; IMMUNOGLOBULIN A; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY PRODUCTION; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZED CHILD; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOGLOBULIN G BLOOD LEVEL; IMMUNOGLOBULIN G MUCOSA LEVEL; IMMUNOLOGICAL PARAMETERS; INFANT; INFLAMMATION; INFORMED CONSENT; MALE; MEDICAL RECORD; MULTIPLEX POLYMERASE CHAIN REACTION; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS CULTURE; VIRUS LOAD; BLOOD; IMMUNOLOGY; MUCOSAL IMMUNITY; PASSIVE IMMUNIZATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

ANTIBODIES, VIRAL; CHEMOKINE CXCL10; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL VACCINES;

EID: 84962561580     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00590-15     Document Type: Article

References (14)

1. Blount RE, Jr, Morris JA, Savage RE. 1956. Recovery of cytopathogenic agent from chimpanzees with goryza. Proc Soc Exp Biol Med 92:544-549. http://dx.doi.org/10.3181/00379727-92-22538.
2. Chanock RM. 1956. Association of a new type of cytopathogenic myxovirus with infantile croup. J Exp Med 104:555-576. http://dx.doi.org/10.1084/jem.104.4.555.
3. The IMpact-RSV Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102: 531-537. http://dx.doi.org/10.1542/peds.102.3.531.
4. Andabaka T, Nickerson JW, Rojas-Reyes MX, Rueda JD, Bacic Vrca V, Barsic B. 2013. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 4:CD006602. http://dx.doi.org/10.1002/14651858.CD006602.pub4.
5. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. 1981. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 98:708-715. http://dx.doi.org/10.1016/S0022-3476(81)80829-3.
6. Glezen WP, Taber LH, Frank AL, Kasel JA. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546.
7. Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S. 1981. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 7:263-271. http://dx.doi.org/10.1002/jmv.1890070403.
8. Van Den Kieboom CH, Ahout IM, Zomer A, Brand KH, de Groot R, Ferwerda G, de Jonge MI. 2015. Nasopharyngeal gene expression, a novel approach to study the course of respiratory syncytial virus infection. Eur Respir J 45:718-725. http://dx.doi.org/10.1183/09031936.00085614.
9. Sande CJ, Cane PA, Nokes DJ. 2014. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants. Vaccine 32:4726-4729. http://dx.doi.org/10.1016/j.vaccine.2014.05.038.
10. Vissers M, Habets MN, Ahout IM, Jans J, de Jonge MI, Diavatopoulos DA, Ferwerda G. 2013. An in vitro model to study immune responses of human peripheral blood mononuclear cells to human respiratory syncytial virus infection. 2013:e50766. http://dx.doi.org/10.3791/50766.
11. Yoshida M, Kobayashi K, Kuo TT, Bry L, Glickman JN, Claypool SM, Kaser A, Nagaishi T, Higgins DE, Mizoguchi E. 2006. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 116:2142. http://dx.doi.org/10.1172/JCI27821.
12. Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC. 2004. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4.J Clin Microbiol 42:1564-1569. http://dx.doi.org/10.1128/JCM.42.4.1564-1569.2004.
13. Roe MF, Bloxham DM, Cowburn AS, O'Donnell DR. 2011. Changes in helper lymphocyte chemokine receptor expression and elevation of IP-10 during acute respiratory syncytial virus infection in infants. Pediatr Allergy Immunol 22:229-234. http://dx.doi.org/10.1111/j.1399-3038.2010.01032.x.
14. De Magistris MT. 2006. Mucosal delivery of vaccine antigens and its advantages in pediatrics. Adv Drug Deliv Rev 58:52-67. http://dx.doi.org/10.1016/j.addr.2006.01.002